Search

Tandem Diabetes Care Inc

Fermé

SecteurSoins de santé

15.64 3.23

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.15

Max

15.83

Chiffres clés

By Trading Economics

Revenu

-775K

-21M

Ventes

7.3M

255M

BPA

-0.31

Marge bénéficiaire

-8.316

Employés

2,500

EBITDA

4.5M

-9.2M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+77.9% upside

Dividendes

By Acuity

Prochains Résultats

5 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-152M

1.2B

Ouverture précédente

12.41

Clôture précédente

15.64

Sentiment de l'Actualité

By Acuity

50%

50%

118 / 339 Classement par Healthcare

Tandem Diabetes Care Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 sept. 2026, 20:02 UTC

News

Tandem Diabetes Care Inc shares fell sharply following a price target reduction from Truist Securities, lowering the target to $28.00 from $31.00 while maintaining a Buy rating.

23 sept. 2026, 20:02 UTC

Tandem Diabetes Care Inc shares fell sharply on Wednesday, breaking a trend of higher daily closes and contrasting with previous upward momentum.

22 sept. 2026, 19:15 UTC

Tandem Diabetes Care Inc shares fell sharply, declining notably since Monday's close and remaining significantly below their 20-day moving average.

17 sept. 2026, 20:07 UTC

Tandem Diabetes Care Inc shares fell sharply, closing lower since Wednesday and finishing near the lower end of its one-month range.

16 sept. 2026, 19:05 UTC

Tandem Diabetes Care Inc is sharply higher on Wednesday, maintaining upward momentum since Tuesday's close despite an earlier pullback from a session high.

11 sept. 2026, 20:01 UTC

Tandem Diabetes Care Inc is trading lower today, breaking a trend of higher daily closes. No specific news has been identified to explain the decline.

10 sept. 2026, 20:03 UTC

Tandem Diabetes Care Inc's shares are lower today, remaining near session lows. Broader market volatility follows the European Central Bank's interest rate hike.

9 sept. 2026, 20:07 UTC

Tandem Diabetes Care shares are lower today amid broader market pressures, with significant selling activity contributing to a session decline. No specific news was identified.

8 sept. 2026, 19:26 UTC

Social Media

Tandem Diabetes Care is advancing amid discussions of Modular Medical's product launch targeting hesitant insulin pump users, with FDA clearance and a new pharmacy contract.

4 sept. 2026, 20:08 UTC

Tandem Diabetes Care Inc shares are lower, continuing a five-session decline amid broader selling pressure following a strong jobs report.

1 sept. 2026, 20:02 UTC

Tandem Diabetes Care is trading lower amid broader economic concerns, including rising oil prices and inflation worries impacting interest rate expectations.

31 août 2026, 20:03 UTC

News

Tandem Diabetes Care Inc shares are higher during Monday's session, rebounding sharply after an initial dip amid broader market volatility from recent economic remarks.

27 août 2026, 20:07 UTC

Tandem Diabetes Care Inc shares are higher today, reflecting a modest overall market gain. No specific news was identified to explain the movement.

25 août 2026, 20:07 UTC

Tandem Diabetes Care shares are lower today, continuing a trend of five consecutive daily declines. Earlier, the stock reached a session high before pulling back.

24 août 2026, 19:36 UTC

News

Tandem Diabetes Care shares are lower today, following a downward trend since Friday. Analysts maintain a "Hold" consensus, with targets ranging from $18 to $40.

21 août 2026, 19:46 UTC

Tandem Diabetes Care Inc. shares are roughly flat today, showing some volatility with a high of 2.13% and a low of -2.80%.

20 août 2026, 20:02 UTC

Tandem Diabetes Care Inc shares are lower amid broader market pressures following Walmart Inc's disappointing earnings report, raising concerns about consumer spending.

19 août 2026, 19:46 UTC

Tandem Diabetes Care Inc. shares are higher, reflecting routine performance amid a broader rebound in stock prices linked to declining bond yields.

18 août 2026, 20:01 UTC

Tandem Diabetes Care is trading higher today, reflecting strong intraday performance despite recent lower finishes. The stock remains above its 20-day moving average.

17 août 2026, 19:46 UTC

News

Tandem Diabetes Care shares are lower as investor caution follows its Q2 earnings report, despite meeting revenue and profit expectations.

14 août 2026, 20:06 UTC

Tandem Diabetes Care shares are lower today amid economic concerns following a disappointing U.S. retail sales report for July. The stock remains above its 20-day moving average.

13 août 2026, 19:16 UTC

Tandem Diabetes Care shares are trading lower today, despite broader market support and an early high. Initial jobless claims rose, indicating potential labor market softening.

12 août 2026, 19:41 UTC

News

Tandem Diabetes Care reported a narrower second-quarter loss of 31 cents per share, with revenues of $254.6 million, as shares rise since Tuesday.

11 août 2026, 19:46 UTC

News

Tandem Diabetes Care reported improved second-quarter results, including a narrower loss and increased revenue, supporting shares' advance during Tuesday's session.

10 août 2026, 19:36 UTC

News

Tandem Diabetes Care reported second-quarter revenue of $254.6 million and reaffirmed its full-year guidance of $1.08 billion, supporting a higher share price today.

7 août 2026, 20:02 UTC

News

Tandem Diabetes Care shares rose after Q2 sales of $254.6 million and adjusted EBITDA of $6.4 million exceeded forecasts, despite RBC lowering its price target to $26.

6 août 2026, 23:02 UTC

News

Tandem Diabetes Care reported Q2 sales of $254.6 million and reaffirmed revenue guidance, with shares trading higher in after-market hours.

5 août 2026, 19:56 UTC

News

Tandem Diabetes Care Inc's shares are declining amid negative sentiment in the insulin sector following Insulet Corp's lowered revenue growth forecast.

4 août 2026, 19:46 UTC

Tandem Diabetes Care Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. Earlier, the stock reached a session high before pulling back.

31 juil. 2026, 19:51 UTC

Tandem Diabetes Care Inc is advancing today, benefiting from positive market sentiment driven by technology stocks, despite pulling back from earlier session highs.

Comparaison

Variation de prix

Tandem Diabetes Care Inc prévision

Objectif de Prix

By TipRanks

77.9% hausse

Prévisions sur 12 Mois

Moyen 27.077 USD  77.9%

Haut 50 USD

Bas 16 USD

Basé sur 14 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

14 ratings

8

Achat

6

Maintien

0

Vente

Sentiment

By Acuity

118 / 339Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.